News

Leadership Transition at Health Catalyst: Dan Burton Steps Down

Leadership Transition at Health Catalyst: Dan Burton Steps Down

Health Catalyst Announces Leadership Transition

In a significant move for the company, Health Catalyst, Inc. (NASDAQ: HCAT), a prominent provider of data and analytics technology in healthcare, has revealed that CEO Dan Burton will be stepping down. Effective June 2026, Burton plans to dedicate time to volunteer opportunities aligned with his personal beliefs and commitments alongside his wife.

Dan Burton's Commitment and Achievements

Burton’s tenure at Health Catalyst has been marked by growth and transformation. He joined the company at its inception in January 2011, initially serving as an investor and advisor when it was just a small team. Throughout the past 15 years, he has transitioned into the role of CEO and played a crucial part in the company's evolution.

A Proven Track Record

Under Burton's leadership, Health Catalyst expanded significantly. The company filed for its initial public offering in 2019 and grew its client base to over 1,100 healthcare organizations, while also increasing its workforce to more than 1,400 employees. Burton oversaw the publication of over 375 client case studies that showcase the impact of data-driven solutions in healthcare, contributing to more than $2.2 billion in measurable improvements across various client projects.

Focus on Team Engagement and Recognition

A driving principle of Burton's leadership has been servant leadership, promoting high levels of employee engagement throughout the organization. Health Catalyst has consistently ranked between the 94th and 99th percentile in employee engagement, as measured by Gallup assessments. This commitment to fostering a positive workplace culture has led to Health Catalyst receiving over 125 Best Workplace Awards since 2013, reinforcing its reputation in the industry.

Commitment to Community Service

Burton’s desire to pursue additional faith-based volunteer opportunities reflects his long-standing commitment to service. Together with his wife, they have planned to engage in mission-oriented roles after his official retirement, indicating a personal dedication to their community and spiritual beliefs.

Looking Ahead

As Burton prepares for this transition, he remains committed to supporting the Board during the CEO search process and will continue to contribute as a member of the Board of Directors. Jack Kane, Chairman of the Health Catalyst Board, expressed gratitude for Burton's leadership and dedication, noting the importance of finding a capable leader for the next chapter of the organization.

This isn’t the first leadership transition at Health Catalyst focused on community and faith. Previous members of the leadership team have also stepped down for similar service commitments. These transitions highlight the company's culture of supporting individual missions that align with its core values.

About Health Catalyst

Health Catalyst (NASDAQ: HCAT) specializes in providing data and analytics technology that seeks to improve healthcare delivery. With a portfolio that includes innovative cloud-based solutions like Health Catalyst Ignite™, the company serves over 1,000 organizations globally. Health Catalyst empowers healthcare professionals to transform complex data into actionable insights for improved patient outcomes. The company’s lasting commitment to its mission has generated billions in meaningful improvements for client organizations.

Frequently Asked Questions

What led to Dan Burton's decision to step down as CEO?

Dan Burton has chosen to step down to pursue volunteer opportunities that align with his faith and personal commitments.

How long has Dan Burton been with Health Catalyst?

Dan Burton has been with Health Catalyst since its founding in January 2011, leading the company for over 15 years.

What impact did Dan Burton have on Health Catalyst's growth?

Under Burton's leadership, Health Catalyst expanded its client base significantly and contributed to measurable improvements exceeding $2.2 billion.

What is the company's mission?

Health Catalyst's mission is to ignite smarter healthcare by leveraging data and analytics for clinical and operational improvements.

Who will lead the search for a new CEO?

The Board of Directors will oversee the search for a new CEO, ensuring that they identify a leader who can steer Health Catalyst into its next chapter.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 115

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 473

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 267

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 0

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 74

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 96

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 224

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 163

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Critical Insights on Rising Breast Cancer in Younger Women

Updated Category News Views 204

Understanding the Alarming Trends in Breast Cancer Recent research has uncovered concerning statistics regarding breast cancer in younger women, specifically those aged 18 to 49. A comprehensive study conducted across multiple outpatient facilities has revealed a significant portion of breast cancer diagnoses among this demographic, raising urgent questions about current...

Continue Reading
Asseta: Transforming Family Office Management with AI Solutions

Updated Category News Views 2347

Asseta Unveils Its Rebrand and Advanced AI Offerings In a significant development, Prismatic has rebranded to become Asseta, a transformation that underscores its dedication to providing innovative financial management solutions tailored specifically for family offices. This transition not only marks a shift in branding but signals a deeper commitment to enhancing the...

Continue Reading
Understanding Microsoft's Recent Options Activity and Trends

Updated Category News Views 124

The Surge in Microsoft Options Trading Investors with substantial capital have adopted a bullish approach towards Microsoft (NASDAQ: MSFT). This trend is essential for both institutional and retail traders alike to grasp their positions in the market. What Unusual Trading Movements Reveal Today, a noteworthy surge in options trades for Microsoft caught our attention...

Continue Reading
Eilean Therapeutics Expands Clinical Trials with ZE74-0282 Innovation

Updated Category News Views 103

Eilean Therapeutics Progresses ZE74-0282 into Clinical Trials Eilean Therapeutics has announced an exciting advancement in their pipeline with the development of ZE74-0282, now entering its first-in-human clinical trials. This innovative treatment aims to battle myeloproliferative neoplasms, particularly focusing on the JAK2 V617F mutated variant that poses significant...

Continue Reading
Supermicro's Open Storage Summit Highlights AI's Storage Revolution

Updated Category News Views 236

Supermicro's Open Storage Summit: A Game Changer The Open Storage Summit, hosted by Super Micro Computer, Inc. (SMCI), is gearing up to make waves in the tech industry. This year marks the sixth installment of the summit, which will be running from August 12 to August 28, featuring nine insightful sessions and the participation of 23 companies and 40 speakers. The event...

Continue Reading